Restarting Therapy in Patients with HIV

Opinion
Video

Addressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy.

BIC = bictegravir

DRV = darunavir

DTG = dolutegravir

F/TAF = FTC/TAF = Emtricitabine/Tenofovir alafenamide

F/TDF = FTC/TDF = Emtricitabine/Tenofovir disoproxil fumarate

B/F/TAF = BIC/FTC/TAF = Bictegravir/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

DTG/ABC/3TC = Dolutegravir/Abacavir/Lamivudine (single tablet regimen)

DTG + F/TAF = DTG + FTC/TAF = Dolutegravir + Emtricitabine/Tenofovir alafenamide (multi-tablet regimen)

D/C/F/TAF = DRV/COBI/FTC/TAF = Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (single tablet regimen)

DTG/3TC = Dolutegravir/Lamivudine (single tablet regimen)

CAB = Cabotegravir

CAB + RPV = Cabotegravir + Rilpivirine

Video content above is prompted by the following question:

  • What treatment regimens do you consider in patients with HIV who have fallen out of care?
Related Videos
A panel of 3 experts on COPD
A panel of 3 experts on COPD
A panel of 4 experts on asthma
A panel of 4 experts on asthma
4 KOLs are featured in this series
4 KOLs are featured in this series
Shauna Applin, ARNP, an expert on HIV
Shauna Applin, ARNP, an expert on HIV
3 KOLs are featured in this program.
3 KOLs are featured in this program.
© 2024 MJH Life Sciences

All rights reserved.